Disclosures

Aminoscope is an independent, reader-supported research and review site, operated by MEAS Partners, LLC, a Delaware limited liability company at 131 Continental Dr, Suite 305, Newark, DE 19713. This page explains how we make money and the firewall between our commercial partnerships and our editorial verdicts. It is written to comply with the U.S. Federal Trade Commission's Guides Concerning the Use of Endorsements and Testimonials in Advertising (16 CFR Part 255) and the FTC's “.com Disclosures” guidance on clear and conspicuous disclosure.

1. FTC Affiliate Disclosure

Aminoscope earns affiliate commissions. When you click links to providers on our site and sign up or make a purchase, we may receive a commission at no additional cost to you. This compensation helps us operate the site, maintain our research, and keep our content free to read. This is a “material connection” within the meaning of 16 CFR Part 255, and we disclose it here, on relevant pages, and near affiliate links so it is clear and conspicuous before you act.

2. Who We Work With

Our outbound partner links are managed primarily through the affiliate network Katalys (Katalys LLC), along with direct partnerships with select telehealth providers and pharmacies that supply peptides, GLP-1 medications, and longevity therapeutics. Each network and partner operates under its own terms and privacy policy. We are not paid to publish a specific opinion, and our participation in any affiliate program does not obligate us to cover a partner favorably — or at all.

3. The Editorial Firewall

A commercial relationship never buys a higher ranking, a softer verdict, or a more favorable safety statement. Our reviews, rankings, and risk assessments are determined by the evidence and our published methodology alone. A provider with an affiliate relationship will not receive a better assessment than one without, and a provider that scores poorly will be described accordingly regardless of any existing or potential commercial relationship.

What commercial relationships can influence: placement and visibility — for example, featured callouts, “top pick” modules, or how often a partner appears across the site. Where a link is commercial or a placement is sponsored, it is labeled as such. What they never influence: the substance of our evidence review, the verdicts we reach, and the safety information we report.

4. Independence and Coverage

Aminoscope is operated by an independent publisher — not a medical provider, pharmacy, or telehealth company. We are not affiliated with any pharmaceutical manufacturer beyond standard affiliate agreements. The site does not cover every available peptide, GLP-1 medication, longevity intervention, or provider; the topics and providers we cover are based on our editorial priorities, reader interest, and the strength of available evidence.

5. Not Medical Advice

Everything here is for research and education. It is not medical advice and not a substitute for individualized care from a licensed clinician, and it does not create a doctor–patient relationship. Peptides, GLP-1 medications, and longevity interventions can have serious side effects and are not appropriate for everyone. Always consult a qualified, licensed healthcare provider before starting, stopping, or changing any medication or intervention. Prices, availability, features, and regulatory status change frequently — verify current details on the provider's own site before acting. See our Terms of Use for the full disclaimer.

6. Trademark Disclaimer

Names and marks including Wegovy®, Ozempic®, Rybelsus® (Novo Nordisk A/S), Mounjaro®, and Zepbound® (Eli Lilly and Company) are the property of their respective owners. Aminoscope uses these names only to identify the products discussed. Use of these marks does not imply endorsement or affiliation. Aminoscope is not affiliated with Novo Nordisk, Eli Lilly, or any other pharmaceutical manufacturer.

7. Privacy and Data

Following an affiliate link may pass a non-identifying referral identifier to the destination, but it does not transmit any personal information about you from us, and our analytics load only after you consent. See our Privacy Policy for how we handle data and your rights under the GDPR and CCPA/CPRA.

8. Corrections and Contact

If you find an error — a misread figure, an outdated citation, a broken link to a source — write to editorial@aminoscope.com and we will correct it promptly and visibly. Questions about these disclosures can be sent to the same address.